No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CVAC CureVac
- 2.330
- +0.020+0.87%
Close Apr 26 16:00 ET
- 2.350
- +0.020+0.86%
Post 17:18 ET
522.63MMarket Cap-982P/E (TTM)
2.420High2.280Low837.61KVolume2.320Open2.310Pre Close1.94MTurnover0.70%Turnover RatioLossP/E (Static)224.31MShares12.36052wk High0.91P/B277.35MFloat Cap2.21552wk Low--Dividend TTM119.04MShs Float151.800Historical High--Div YieldTTM6.06%Amplitude2.215Historical Low2.318Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | CureVac NV : UBS Cuts Target Price to $14 From $18
Curevac's Market Forecast Risks: Miscalculations and Trial Participant Challenges Threaten Profitability
Express News | CureVac Shares Are Trading Lower After Leerink Partners Downgraded the Stock From Outperform to Market Perform and Lowered Its Price Target From $12 to $4
CureVac Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/25/2024 60% Leerink Partners $12 → $4 Downgrades Outperform → Market Perform 04/05/2024 — Guggenheim R
Analysts Offer Insights on Healthcare Companies: CureVac (CVAC) and BioMarin Pharmaceutical (BMRN)
Express News | CureVac NV : Leerink Partners Cuts Target Price to $4 From $12
Comments
My Depot: Stocks to sell or HODL
Over the years I bought amongst others some (hyped) stocks that turned out to be a loss. Which of the following stocks might have a bright Future, which should I better sell asap?
Aurora Cannabis
Curevac
Canopy Growth
Bayer
3M
Alibaba
Tencent
NFLX
Nokia
$Netflix(NFLX.US$$3M(MMM.US$$TENCENT(00700.HK$$Alibaba(BABA.US$
Aurora Cannabis
Curevac
Canopy Growth
Bayer
3M
Alibaba
Tencent
NFLX
Nokia
$Netflix(NFLX.US$$3M(MMM.US$$TENCENT(00700.HK$$Alibaba(BABA.US$
4
3
Update
$CureVac(CVAC.US$ CureVac and Md Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines
1
2
News
$CureVac(CVAC.US$ CureVac Announces Phase 2 Interim Data From Seasonal Influenza Vaccine Development Program in Collaboration With GSK
Benzinga· 1 min ago
Benzinga· 1 min ago
15
占据了
Watching closely
$CureVac(CVAC.US$ CureVac Unveils Positive Phase 2 Interim Data From COVID-19 Vaccine Development Program In Collaboration With GSK Providing Strong Validation of Proprietary Technology Platform
$CureVac(CVAC.US$ I bought,my opinion market fear people way over sell.good do buy ask me
2
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
BigBadBear : None of the above bro. Sorry
Darth Magnavox : buy Aurora canopy bayer 3M sell the rest
71229336Bedbugguy : ACB to the moon own -10000